Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells

Journal of Clinical Investigation

Volumn 120, Issue 7, 2010, Pages 2610-2618

  Watarai, Hiroshi ^a,b   Fujii, Shin Ichiro ^a   Yamada, Daisuke ^a,b   Rybouchkin, Andrei ^a   Sakata, Sakura ^a   Nagata, Yuko ^a   Iida Kobayashi, Midori ^a,b   Sekine Kondo, Etsuko ^a   Shimizu, Kanako ^a   Shozaki, Yohei ^a   Sharif, Jafar ^a   Matsuda, Masashi ^a   Mochiduki, Shinobu ^a   Hasegawa, Takanori ^a   Kitahara, Genta ^a   Endo, Takaho A ^c   Toyoda, Tetsuro ^c   Ohara, Osamu ^a   Harigaya, Ken Ichi ^d   Koseki, Haruhiko ^a,b   Taniguchi, Masaru ^a   more..

^a Institute of Physical and Chemical Research   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c RIKEN   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR; 1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; ALPHA GALACTOSYLCERAMIDE; ALPHA-GALACTOSYLCERAMIDE; CYTOKINE; GALACTOSYLCERAMIDE; GLYCOLIPID; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ARTICLE; FEMALE; FIBROBLAST; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TH1 CELL; TUMOR GROWTH; ANIMAL; CELL DIFFERENTIATION; DRUG EFFECT; IMMUNOLOGY; NEOPLASM; SPLEEN;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; GALACTOSYLCERAMIDES; GLYCOLIPIDS; INDUCED PLURIPOTENT STEM CELLS; MICE; NATURAL KILLER T-CELLS; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; SPLEEN;

EID: 77954992770     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI42027     Document Type: Article

References (31)

1. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol. 2003;21:483-513.
2. - T cells in mice and humans. J Exp Med. 1994;180(3):1097-1106.
3. - T cells. J Exp Med. 1997;186(1):109-120.
4. Fujii S, Shimizu K, Hemmi H, Steinman RM. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunol Rev. 2007;220:183-198.
5. Cui J, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 1997;278(5343):1623-1626.
6. Terabe M, Berzofsky JA. The role of NKT cells in tumor immunity. Adv Cancer Res. 2008;101:277-348.
7. Dhodapkar MV. Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges. Front Biosci. 2009;14:796-807.
8. Okai M, et al. Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox Sang. 2002;83(3):250-253.
9. + NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood. 2004;103(2):383-389.
10. Chang DH, et al. Sustained expansion of NKT cells and antigen-specific T cells after injection of alphagalactosyl-ceramide loaded mature dendritic cells in cancer patients. J Exp Med. 2005;201(9):1503-1517.
11. Motohashi S, et al. A phase I-II study of alphagalactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J Immunol. 2009;182(4):2492-2501.
12. Motohashi S, et al. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res. 2006;12(20 pt 1):6079-6086.
13. Watarai H, et al. Generation of functional NKT cells in vitro from embryonic stem cells bearing rearranged invariant V{alpha}14-J{alpha}18 TCR{alpha} gene. Blood. 2010;115(2):230-237.
14. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
15. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313-317.
16. Wernig M, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448(7151):318-324. (Pubitemid 47080337)
17. Savagem AK, et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity. 2008;29(3):391-403.
18. Kovalovsky D, et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol. 2008;9(9):1055-1064.
19. Nichols KE, et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med. 2005;11(3):340-345.
20. Pasquier B, et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med. 2005;201(5):695-701.
21. Gonzalez-Aseguinolaza G, et al. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med. 2002;195(5):617-624.
22. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by alphagalactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med. 2003;198(2):267-279.
23. Hermans IF, et al. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol. 2003;171(10):5140-5147.
24. Fujii S, et al. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc Natl Acad Sci U S A. 2006;103(30):11252-11257.
25. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007;1(1):39-49.
26. Hanna J, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell. 2008;133(2):250-264.
27. Hong H, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009;460(7259):1132-1135.
28. Osafune K, et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol. 2008;26(3):313-315.
29. Bolstad BM, Collin F, Simpson KM, Irizarry RA, Speed TP. Experimental design and low-level analysis of microarray data. Int Rev Neurobiol. 2004;60:25-58.
30. Cho SK, Zúñiga-Pflücker JC. Development of lymphoid lineages from embryonic stem cells in vitro. Methods Enzymol. 2003;365:158-169.
31. Watarai H, Nakagawa R, Omori-Miyake M, Dashtsoodol N, Taniguchi M. Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat Protoc. 2008;3(1):70-78.